News J&J hopes FDA cardio label will limit Invokana damage Diabetes drug has been hit by amputation warning on label.
News More data supports Jardiance lead in cardiovascular battle Cardioprotective effect occurred in patients independently of blood sugar control
News New Apple Watch to feature enhanced heart health tracking Heart Rate app will feature in FDA and Stanford study.
News Verily developing AI-based heart disease test Deep learning AI analyses retinal images to determine heart disease risk.
News New heart attack data boost AZ’s Brilinta A new sub-analysis of data from a phase 3 trial shows AstraZeneca’s Brilinta cuts the risk of cardiovascular death by 29% in high risk patients.
News Daiichi Sankyo anticoagulant gains EU label boost Label gives guidance in use when restoring normal heart rhythm
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
